Related Experiment Video
Updated: Mar 17, 2026
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma
Xiao-Dong Huang1, Feng-Jun Xiao2, Shao-Xia Wang2
1Department of General Surgery, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Abstract:
Liposarcoma(LPS) is the most common type of soft tissue sarcoma accounting for 20 % of all adult sarcomas. However, the molecular pathogenesis of this malignancy is still poorly understood. Here, we showed that GPS2 expression was downregulated in LPS and correlated with the prognosis of this disease. In vitro study showed that knockdown of GPS2 resulted in enhanced proliferation and migration of LPS cell line SW872, without significant influence of cell death. Conclusively, our results suggest that GPS2 may act as a tumor suppressor in LPS and serve as a potential prognosis marker for this disease.
Insights
GPS2 acts as a tumor suppressor in liposarcoma (LPS), a common soft tissue sarcoma. Lower GPS2 expression correlates with poor prognosis, suggesting its potential as a diagnostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Liposarcoma (LPS) is the most prevalent soft tissue sarcoma in adults, representing 20% of all adult sarcomas.
- The precise molecular mechanisms driving liposarcoma development remain largely unknown.
- Understanding the genetic and molecular underpinnings of LPS is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of GPS2 in the molecular pathogenesis of liposarcoma.
- To determine the correlation between GPS2 expression levels and liposarcoma patient prognosis.
- To explore the functional impact of GPS2 on liposarcoma cell behavior in vitro.
Main Methods:
- Analysis of GPS2 expression levels in liposarcoma tissues.
- Correlation analysis between GPS2 expression and clinical prognosis.
- In vitro knockdown of GPS2 in the liposarcoma cell line SW872.
- Assessment of cell proliferation, migration, and cell death following GPS2 knockdown.
Main Results:
- GPS2 expression was found to be significantly downregulated in liposarcoma.
- Reduced GPS2 expression correlated with a poorer prognosis for liposarcoma patients.
- Knockdown of GPS2 in SW872 cells led to increased proliferation and migration.
- GPS2 knockdown did not significantly affect cell death in the studied liposarcoma cell line.
Conclusions:
- GPS2 functions as a tumor suppressor in liposarcoma.
- GPS2 may serve as a valuable prognostic biomarker for liposarcoma.
- Targeting GPS2 or understanding its regulatory pathways could offer new therapeutic strategies for liposarcoma.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes